Maria Vyskocilova (Holicka)
Cardiology Consultant
Brno,642
Summary
Dynamic Cardiology Consultant with expertise in cardiac imaging and a proven track record in establishing specialized care for cardiomyopathy patients at University Hospital Brno. Successfully reduced hospital readmission rates through innovative telemedicine follow-up and patient education, while mentoring medical residents and fostering a collaborative learning environment.
Overview
14
14
years of professional experience
1
1
Certification
4
4
Languages
Work History
Cardiology Consultant
Masaryk Memorial Cancer Institute
09.2020 - Current
- Established a cardio-oncology care for outpatient and inpatient cardiac management of oncology patients
- Multidisciplinary approach to provide comprehensive cardiac care at tertiary cardiologic center
Assistant Professor
Faculty Of Medicine, Masaryk University
09.2017 - Current
- Managing the clinical education for final-year medical students at our department
- Leading differential diagnosis classes at the Simulation Centre of the Faculty of Medicine of Masaryk University
Cardiology Consultant
Department of Internal Medicine and Cardiology, University Hospital
09.2011 - Current
- Establishing a specialized outpatient care for cardiomyopathy patients. Managed the hospital-wide drug registration process for medications such as mavacamten and tafamidis. Successfully introduced these new specific therapies to our patients.
- Reduced hospital readmission rates for patients with chronic hearth failure through effective follow-up care and patient education with telemedicine
- Mentoring medical residents and fellows
Education
Board Certification - Cardiology
04.2001 -
Board Certification - Internal Medicine
04.2001 -
Board Certification in Cardiology - General Medicine
04.2001 -
Skills
Cardiac imaging expertise
Selected publications
- Řiháčková, E., Řiháček, M., Bouček, L., Vyskočilová, M., Elbl, L. Utility of global longitudinal strain in early identification of chronic cardiotoxicity in asymptomatic long-term malignant lymphoma survivors with normal left ventricle ejection fraction. SCIENTIFIC REPORTS , 15(1). (2025)
- Řiháčková, E., Řiháček, M., Vyskočilová et al. Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma-a review and prospects for the future. Frontiers in Cardiovascular Medicine , 10. (2023)
- Holická, M., Čučková, P., Hnátková, K., Koc, L., Ondrúš, T., Lokaj, P., Pařenica, J., Novotný, T., Kala, P., & Malík, M. In Comparison to Pathological Q Waves, Selvester Score Is a Superior Diagnostic Indicator of Increased Long-Term Mortality Risk in ST Elevation Myocardial Infarction Patients Treated with Primary Coronary Intervention. Diagnostics , 11(5). (2021)
- Pešl, M., Jelínková, Š., Caluori, G., Holická, M., Krejčí, J., Němec, P., et al. Cardiovascular progenitor cells and tissue plasticity are reduced in a myocardium affected by Becker muscular dystrophy. Orphanet Journal of Rare Diseases , 15(1). (2020)
- Holická, M., Novotný, T. Léčba arytmické bouře u pacienta se syndromem Brugadových. Cor et Vasa Case Reports , 2019(2), 48-51. (2019)
- Pazdernik, M., Gabrlikova, A., Riskova, T., Novakova, T., Holicka, M., Kala, P., Rozhonova, M., Uddim, H., Grapsa, J., Laudari, S., & Tiwari, K. Cardiac screening in Nepal. European heart journal , 39(5), 452. (2018)
Selected invited presentations
- Atrial fibrillation from a clinical perspective. New Frontiers in Basic Cardiovascular Research, Sete, France . (2024)
- New therapeutic options for HCM – mavacamten. Cardiomyopathy Day, I. IKAK, Brno, Czech Republic . (2024)
- Hypertrophic Septet - interactive case reports. XXXI. Annual Congress of the Czech Society of Cardiology, Brno, Czech Republic . (2023)
- Heart Failure Clinic with a telemedicine program. XXXI. Annual Congress of the Czech Society of Cardiology, Brno, Czech Republic . (2023)
- Panel discussion on cardiomyopathies. Modern Trends in Interventional Cardiology, Brno Czech republic . (2023)
- Left ventricular hypertrophy and what next? Step by step diagnose. XXX. Annual Congress of the Czech Society of Cardiology, Brno, Czech Republic . (2022)
- Reversible Myocardial Dysfunction. Cardiomyopathy Day I. IKAK, Brno, Czech Republic . (2023)
- Hypertrophy 5x differently. XXVI. Annual Conference of the Czech Heart Failure Society, Olomouc, Czech Republic . (2022)
- Cardiomarkers and Cardiotoxicity. Oncology Days, Brno, Czech Republic . (2022)
- Exotic cases (post-rheumatic heart disease in Ethiopia).XXVII. Annual Congress of the Czech Society of Cardiology, Brno, Czech Republic . (2019)
- Intention to treat primary PCI in STEMI with full ST-segment resolution on admission. International Congress on Coronary Artery Disease, Florence, Italy. (2015)
Selected led workshops and webinars
- Story of the family with Fabry disease . Roadshow - Diagnosis of heart diseases. https://www.tribune.cz/kongresy/roadshow-2025/roadshow-diagnostika-onemocneni-srdce/fabryho-choroba-pribeh-pacientky-jarmily-a-jejiho-otce-frantiska/ Czech republic (2025)
- Workshop on Myocardial Hypertrophy. Slovak society of cardiology. Tatranské kardiofórum, Štrbské Pleso, Slovakia. (2024)
- Workshop on Echocardiography. Czech society of cardiology. III.Congress of the KardioTech, Milovy, Czech Republic. (2023)
- Connecting Fabry disease. Accredited webinar. https://www.solen.cz/ec/ele_02A_0432_00_Jak_neprehlednout_pacienta_s_Fabryho_ chorobou_v_praxi_kardiologa.php, Prague, Czech republic (2024)
Book Chapters
- Vyskočilová, M. TTR Amyloidosis (Chapter XX.3, pp. 477-495). In: Elbl, L., Kala, P. (eds.), Clinical Cardio-oncology. Grada Publishing, a.s. (2025)
- Vyskočilová, M. Immunomodulatory agents (Chapter II.8, pp. 61-66). In: Elbl, L. (eds.), Clinical Cardio-oncology. Grada Publishing, a.s. (2025)
- Vyskočilová, M. Proteasome inhibitors (Chapter II.9, pp. 67-73). In: Elbl, L. (eds.), Clinical Cardio-oncology. Grada Publishing, a.s. (2025)
- Vyskočilová, M., Elbl, L. Vascular cerebral strokes in oncology patients (Chapter XVIII, pp. 433-442). In: Elbl, L., Kala, P. (eds.), Clinical Cardio-oncology. Grada Publishing, a.s. (2025)
- Vyskočilová, M., Elbl, L. Echocardiography (Chapter IV.1, pp. 145-158). In: Elbl, (eds.), Clinical Cardio-oncology. Grada Publishing, a.s. (2025)
- Vyskočilová, M., Elbl, L., Radvan, M., & Řiháčková, E. Cardio-oncology and Interdisciplinary Issues (Chapter 2.21). In: Souček, M. (lead author), Internal Medicine, 2nd completely revised edition. Grada Publishing, a.s. (2025)
Certification
GCP Training
Clinical trials
D7960C00015 Azure, AstraZeneca
VICTORION-2 PREVENT Study_Paraxal, Novartis
MK2870-005 - A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician’s Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Immunotherapy (MK-2870-005/ENGOT-en23/GOG3095)
Timeline
GCP Training
07-2025
Cardiology Consultant - Masaryk Memorial Cancer Institute
09.2020 - Current
Assistant Professor - Faculty Of Medicine, Masaryk University
09.2017 - Current
Cardiology Consultant - Department of Internal Medicine and Cardiology, University Hospital
09.2011 - Current
First Faculty of Medicine, Charles University - Board Certification, Cardiology
04.2001 -
Institute of Postgraduate Health Education - Board Certification, Internal Medicine
04.2001 -
First Faculty of Medicine, Charles University - Board Certification in Cardiology, General Medicine
04.2001 -